Jefferies, Apple

Fluence Energy slides as Jefferies downgrades on margin concerns
Fluence Energy (NASDAQ:FLNC) -6.1% in Wednesday's trading to its lowest in nearly six months as Jefferies downgrades shares of the energy storage company to Hold from Buy with a $15 price target, cut from $22,
Apple Stock Downgraded by Loop Capital and Jefferies Amid Concerns on Growth Prospects
Ananda Baruah, analyst from Loop Capital, downgraded Apple from "Buy" to "Hold," with a revised price target of $230, down from $275. The analyst concerned over iPhone demand reduction since March 2024.
Apple downgraded to Underperform from Hold at Jefferies
Jefferies analyst Edison Lee downgraded Apple (AAPL) to Underperform from Hold with a price target of $200.75, down from $211.84.Invest with
Apple dips after Jefferies cuts rating to Underperform
Jefferies downgraded Apple's (NASDAQ:AAPL) rating to Underperform from Hold noting that it expects results and guidance to miss estimates. Shares of Apple fell about 2% premarket on Tuesday. The firm also lowered the price target on the shares to $200.
Jefferies Downgrades Apple (AAPL)
Fintel reports that on January 21, 2025, Jefferies downgraded their outlook for Apple (NasdaqGS:AAPL) from Hold to Underperform. Analyst Price Forecast Suggests 7.89% Upside As of December 23, 2024, the average one-year price target for Apple is $248.
Apple Downgraded by Jefferies Amid Weak iPhone Sales and AI Concerns
Jefferies analysts downgraded Apple (NASDAQ:AAPL) stock to Underperform from Hold, reducing the price target to $200.75 from $211.84, signaling a potential 13% downside. The downgrade reflects concerns over Apples
Apple Stock Falls as Jefferies Downgrades; JPM Lowers Price Target
KEY TAKEAWAYS Apple shares fell Tuesday after Jefferies downgraded the stock to an “underperform” from “hold” on ...
bovnews41m
Meta Platforms Inc (META) Stock Rated Buy by Jefferies
Meta Platforms Inc (META) stock saw a modest uptick, ending the day at $616.46 which represents a slight increase of $3.69 or 0.60% from the prior close of $612.77. The stock opened at $617.83 and ...
Jefferies Sticks to Its Buy Rating for Netflix (NFLX)
In a report released today, James Heaney CFA from Jefferies maintained a Buy rating on Netflix (NFLX – Research Report), with a price target of ...
Jefferies' profit jumps on investment banking windfall
Jefferies Financial's profit more than tripled in the fourth quarter as the investment bank earned higher fees from advising ...
bovnews22h
Jefferies Issues Hold Rating for Pinterest Inc (PINS) Stock
Pinterest Inc (PINS) stock saw a modest uptick, ending the day at $30.53 which represents a slight increase of $0.14 or 0.46% from the prior close of $30.39. The stock opened at $30.78 and touched a ...
Traders Magazine1d
Jefferies Raises $10m to Support Los Angeles Wildfire Relief
Jefferies announced that it will donate $10 million to charities providing aid for first responders and the people and ...
GE HealthCare Stock Gains After Jefferies Analysts Name It 'Franchise Pick'
GE HealthCare Technologies shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a ...
3 UK industrial stocks downgraded at Jefferies this week
Jefferies analysts this week downgraded three leading UK industrial stocks, namely Judges Scientific (LON:JDG), Smiths Group (OTC:SMGZY), and XP (NASDAQ:XP) Power (LON:XPP). The rating for all three ...
Apple falls 2% to $225.04 after Jefferies cuts to sell, Loop to hold
EST Apple (AAPL) falls 2% to $225.04 after Jefferies cuts to sell, Loop to holdInvest with Confidence: Follow TipRanks' Top Wall Street ...
Stock to buy today: Citi sees 17% upside in Paytm; Jefferies maintain buy on Dalmia Bharat
Brokerage firms remain optimistic about Dalmia Bharat, KEI Industries, and Paytm despite sectoral challenges. Jefferies ...
Crinetics upgraded to buy by Jefferies, atumelnant potential cited
Jefferies has upgraded Crinetics Pharmaceuticals (NASDAQ:CRNX) to buy, citing a recent pullback in the stock on investor concerns about Phase 2 data for the company's drug atumelnant in the treatment ...